Milpro Broad Spectrum Allwormer Dog 11 - 55lbs 48 Tablets

General Directions:

• Animals should be weighed to ensure accurate dosing. Milpro tablets have a liver flavoured coating to increase palatability. The tablets may be hidden in food or may be accepted from the hand.
• Half tablets may be kept for use in the original blister for up to six months after the first half was used.
• When administering MILPRO be certain that the entire dose is consumed. Watch for several minutes following treatment to be sure that the entire dose has been eaten. lf the entire dose is not eaten, redose as soon as possible, with the full dose.
• Fleas are intermediate hosts for tapeworm (Dipylidium caninum). Effective flea control will reduce the incidence of tapeworm.
• If worm problems persist, consult a veterinarian.

For Dogs:

The dog formulation is not suitable for use in cats.

• Treats and controls roundworm (Toxocara canis, Toxascaris leonina), whipworm (Trichuris vulpis), hookworm (Ancylostoma caninum, Ancylostoma braziliense) and tapeworm infections (Dipylidium caninum, Taenia spp., Echinococcus granulosus). Also prevents heartworm (Dirofilaria immitis).
• Adult dogs should be treated every 3 months unless lifestyle factors indicate a tailored treatment protocol.
• Pregnant bitches should be treated at mating, then 10 days before whelping, then every three months.
• For whipworm, treat every six to eight weeks after three months of age. In hydatid tapeworm areas, dogs should be dosed every six weeks or on veterinary advice.
• Pets should not be fed, or allowed to feed on, offal from any species.
• For heartworm prevention, MILPRO must be administered orally every month, preferably on the same date each month. If you miss the 30-day interval by no more than 7 days, administer immediately, and resume your monthly dosing schedule. If the interval is longer than 7 days, consult your veterinarian before recommencing the dosing schedule.

• Caution should be taken in the case of concurrent use of the product and
  other macrocyclic lactones.
• Studies with milbemycin oxime indicate that the margin of safety in certain dogs of Collie or related breeds is less than in other breeds. In these dogs, the recommended dose should be strictly observed.
• Clinical signs in Collies are similar to those seen in the general dog population when overdosed.
• MILPRO, given monthly, may be used for the prevention of heartworm infection. In heartworm risk areas, or in the case of unknown heartworm status, an examination for existing heartworm infection prior to commencement of treatment is recommended. The use in dogs suffering from microfilaremia is not recommended. Consult a veterinarian.
• The safety of Milpro in heartworm positive cats has not been established.
  An examination for existing heartworm infection prior to commencement
  of treatment is recommended. Consult a veterinarian.